جستجوی استاد راهنمای دانشگاهی

Prof. Mike Boxem is a Professor in the Department of Biology at Utrecht University's Faculty of Science, specializing in Developmental Biology. His research focuses on epithelial polarity, cell polarity complexes, and C. elegans genetics. He holds a PhD from Utrecht University (2002) and completed postdoctoral work at the Dana-Farber Cancer Institute. Notable honors include the NWO Vici (2016), NWO Vidi (2010), and ECHO grants. He leads the PolarNet Marie Curie ITN network and has supervised 8 research projects. His work contributes to understanding cell polarity mechanisms and developmental processes in C. elegans. Educations: BSc Medical Biology, VU University Amsterdam PhD in Biology, Utrecht University (2002) Research Interests: Boxem’s lab investigates how cell polarity complexes regulate epithelial tissue organization in C. elegans. Key topics include Crumbs polarity proteins, intermediate filaments, and signaling pathways controlling lumen formation and germline development. His work integrates genetic, biochemical, and imaging approaches to dissect molecular mechanisms underlying polarity establishment and maintenance. Grants & Awards: NWO Vici Grant (2016) - Supports long-term research NWO Vidi Grant (2010) - Established his independent lab ECHO Grant (2014) - European funding for collaborative projects Labs/Teams: His group is part of the Biodynamics and Biocomplexity research division. Collaborations span global networks, including the PolarNet consortium focusing on epithelial polarity.

• Developmental Biology
• Cell Polarity
• Protein-Protein Interactions
• +۳ مورد دیگر

Prof. Roland J. Pieters is a Full Professor of Chemical Biology and Drug Discovery at Utrecht University, leading research in glycodrugs and protein-carbohydrate interactions. He earned his MSc from the University of Groningen (1990) and PhD from MIT (1995), followed by postdoctoral research at ETH Zurich and Utrecht University. His work focuses on multivalent carbohydrate systems targeting bacterial and viral adhesion proteins, including lectins like LecA and Shiga toxin. He has held grants such as the VICI (2008) and a KNAW fellowship (1999), and chairs the Chemical Biology of Multivalent Systems. His research group uses glyco-microarrays and advanced inhibitors to combat pathogens, with applications in vaccines and antivirals. Key achievements include developing polymer-based cholera toxin inhibitors and anti-influenza agents. He contributes to education as a Program Leader in the Pharmaceutical Sciences department and serves on editorial boards, including Molecules (Chemical Biology section). Education: M.Sc., University of Groningen, 1990 Ph.D., MIT, 1995 Research Interests: Glycodrugs, protein-carbohydrate interactions, multivalency, and drug discovery with an emphasis on bacterial/viral adhesion inhibition and immune modulation. His lab designs inhibitors using rigid spacers and explores O-GlcNAc transferase (OGT) inhibitors for therapeutic applications. Grants & Awards: 2023: VICI grant (NWO) 1999: KNAW Fellowship Teaching & Service: Program Leader for Pharmaceutical Sciences education since 2006, member of examination committees, and curriculum developer for Molecular Life Sciences programs. Editorial role in Chemical Biology (Molecules). Labs/Teams: Leads the Chemical Biology and Drug Discovery department, focusing on glycobiology, antiviral strategies, and carbohydrate-based therapeutics.

• Organic Chemistry
• Medicinal Chemistry
• Chemical Biology
• +۴ مورد دیگر

Kyria Boundy-Mills is a Professional Research Microbiologist at the University of California, Davis in the Department of Food Science and Technology , where she has curated the Phaff Yeast Culture Collection since 2001. She maintains this global resource of 9,000 yeast strains for academic, industrial, and governmental researchers. Current research focuses on yeast/insect ecology Screening yeasts for protein, lipid, and carotenoid production Microbial interactions in food fermentations Applications in biofuels and biotechnology Her publications highlight collaborations across entomology, biotechnology, and food microbiology, with applications in wine fermentation, fruit pests, and biofuel production. Awards include the UC Davis Academic Federation Award for Excellence in Research (2015) and the American Society for Microbiology USFCC/J. Roger Porter Award (2016). She advises undergraduate researchers in her lab and contributes to culture collection management standards through the United States Culture Collection Network. Her work intersects microbial diversity, ecological interactions, and industrial innovation.

• Yeast Ecology
• Biotechnology
• Microbial Interactions
• +۵ مورد دیگر

Yong Zeng is an Associate Professor in the Department of Chemistry at the University of Florida. He leads the Zeng Group, focusing on precision medicine through innovative micro/nanoscale technologies. His research bridges chemistry, materials science, bioengineering, and medicine to develop tools for non-invasive cancer and Alzheimer’s disease diagnosis. Key projects include lab-on-a-chip systems, exosome-based liquid biopsy platforms, and CRISPR-driven diagnostic assays. Education: Ph.D., Chemistry, University of Alberta (2007) Postdoctoral Research, University of California, Berkeley (2008-2012) Research Interests: Dr. Zeng’s work centers on creating transformative technologies for precision diagnostics, including nano-engineered microfluidic devices, smart bioanalyzers with AI integration, and exosome-based biomarker analysis. His group has pioneered methods for detecting extracellular vesicles, proteins, nucleic acids, and glycans in blood samples. Awards: 2013 Bioanalysis Young Investigator Award Grants & Collaborations: Supported by NIH grants, his lab collaborates with clinicians and biologists to translate technologies into clinical tools. Notable collaborations include exosome research for precision immunotherapy and liquid biopsy-based cancer diagnosis. Labs/Teams: The Zeng Group operates at the interface of engineering and medicine, emphasizing translational research to bridge laboratory innovations with clinical applications.

• Precision Medicine
• Nanotechnology
• Biomarker Development
• +۶ مورد دیگر

Ellen Rothenberg is the Edward B. Lewis Professor of Biology at the California Institute of Technology (Caltech). She earned her A.B. in Biochemical Sciences from Harvard University (1972) and a Ph.D. in Molecular Biology from MIT (1977). Her academic career at Caltech spans roles from Assistant Professor (1982–88) to her current position. She holds the Ruddock Professorship (2007–21), Distinguished Professor (2021–), and Lewis Professor (2021–). Her research focuses on transcriptional networks governing T-cell development and signaling, particularly how hematopoietic stem cells commit to T-lymphocyte lineages. Using in vitro systems, molecular genetics, and genomic approaches, her lab explores transcription factor interactions, chromatin dynamics, and signaling pathways that drive T-cell identity. Key interests include understanding stem-cell multipotentiality loss, irreversible commitment mechanisms, and links to autoimmune predisposition. Rothenberg is an Andrew D. White Professor-at-Large at Cornell University (2021–2027), collaborating with immunology and molecular biology departments. She has organized international conferences, served on NIH review panels, and advises biotech firms like Century Therapeutics. Her honors include membership in the National Academy of Sciences, AAAS and American Academy of Arts and Sciences fellowships, and the Feynman Teaching Prize (2016). Education: A.B., Harvard University, Biochemical Sciences, 1972 Ph.D., Massachusetts Institute of Technology, Molecular Biology, 1977 Awards: AAAS Fellow, American Academy of Arts and Sciences Fellow Member, National Academy of Sciences American Association of Immunologists Distinguished Fellow Richard P. Feynman Prize for Excellence in Teaching (2016) External Roles: Cornell’s ADW-PAL (2021–2027), collaborating with faculty hosts Brian Rudd and Andrew Grimson Scientific Advisor, Century Therapeutics, A2 Biotherapeutics, Kite Pharma Her work bridges basic research and clinical applications, including immunogenomics symposia and public lectures on T-cell programming. Ongoing projects explore evolutionary origins of lymphocyte development through comparative analysis of basal vertebrates.

• Cellular and Developmental Biology
• Molecular Biology
• Immunology
• +۳ مورد دیگر

Erik Demaine is a Professor in the Department of Electrical Engineering and Computer Science at MIT, affiliated with the Computer Science and Artificial Intelligence Laboratory (CSAIL), the Theory of Computation group, and the Algorithms Group. His research spans algorithms, computational geometry, folding, robotics, complexity theory, and interdisciplinary connections between mathematics and art. He received the MacArthur Fellowship ("genius grant") for his work on folding and computation. Demaine's work includes co-authoring books such as Geometric Folding Algorithms and Games, Puzzles, and Computation . His art collaborations with his father Martin Demaine, including curved-crease sculptures, are in the permanent collections of the Museum of Modern Art (MoMA) and the Renwick Gallery. He is also involved in software projects like Coauthor and Cocreate, supporting collaborative research and education. His research interests include folding and unfolding of geometric structures, computational complexity of games, protein folding, and algorithm design. He has contributed to areas like data structures, robotics, and network computing, with a focus on bridging theoretical computer science and tangible applications. Demaine holds patents and has been recognized with numerous awards, including the NSERC Doctoral Prize and the Gödel Prize. His work often involves supercollaboration, emphasizing open problem-solving and interdisciplinary approaches.

• Algorithms
• Computational Geometry
• Complexity Theory
• +۵ مورد دیگر

Carmen Moraru is a Professor in the Department of Food Science at Cornell University's College of Agriculture and Life Sciences (CALS). Her research focuses on enhancing food safety, quality, and shelf life through advanced processing methods such as membrane separation, light-based technologies, high-pressure processing (HPP), and microwave vacuum drying. She also studies intermolecular interactions in foods and nanoscale surface engineering to prevent microbial contamination. Dr. Moraru teaches courses like Food Processing and Engineering (FDSC 4250) and co-instructs Advanced Food and Bioprocessing Systems (FDSC 6650) . Her lab, the Moraru Lab, explores emerging technologies in food safety and processing, with recent projects addressing microbial inactivation, nanomaterials, and sustainable drying methods. She advises multiple graduate students and has supervised notable projects, including studies on pea protein functionality and antimicrobial surfaces. Education: Doctorate in Food Science (PhD details not explicitly stated in provided texts). Lab Affiliations: Moraru Lab at Cornell University. Her scientific awards include the Kosi Award in Food Science (2019) and recognition for student achievements like Andreea Beldie's 2019 ADSA Poster Competition win. Recent publications highlight innovations in UV-C light disinfection, microwave drying, and nanotopography-based antimicrobial surfaces. Research collaborations span industry and academia, addressing challenges in dairy processing, plant-based foods, and food packaging safety. Her work frequently integrates computational modeling, experimental validation, and interdisciplinary approaches to solve complex food engineering problems.

• Food Processing and Engineering
• Food Safety Engineering
• Nanotechnology
• +۵ مورد دیگر

Dr. Anand Krishnan serves as Assistant Professor in the Department of Anatomy, Physiology and Pharmacology at the University of Saskatchewan's College of Medicine, where he leads research on nerve-tumor interfaces and neural macrophage biology. His work bridges neuroscience and oncology to identify therapeutic targets for cancer and neurodegenerative disorders. Education: Postdoctoral Fellow, Division of Neurology, University of Alberta, Canada Postdoctoral Fellow, Clinical Neurosciences, University of Calgary, Canada PhD in Biotechnology (Cancer Biology), Rajiv Gandhi Centre for Biotechnology, India Master of Pharmacy (Pharmacology), Manipal University, India Pharma R&D Experience: Orchid Chemicals and Pharmaceuticals Limited; Alembic Pharmaceuticals Limited Dr. Krishnan's research program investigates two core areas: molecular mapping of tumor-nerve interfaces to uncover novel therapeutic targets, and defining the roles of self-renewing resident macrophages in nervous system homeostasis and disease. His lab employs proteomics, murine models, and in vitro neuronal cultures to explore how tumors and nerves mutually support growth through neural invasion and autonomic signaling. Analysis of his 2020-2024 publications reveals consistent focus on neuro-oncology mechanisms, particularly peripheral nerve regeneration pathways (Myc interactome, growth-primed DRG), tumor-nerve crosstalk (sympathetic signaling in prostate cancer), and neurodegenerative targets (MANF). Key methodologies include comparative proteomics, molecular mapping, and drug repurposing screens. Research Funding: Natural Sciences and Engineering Research Council (NSERC) Cancer Research Society (CRS) CIHR Institute of Cancer Research Breast Cancer Society of Canada (BCSC) Prostate Cancer Fight Foundation (PCFF) & Ride for Dad Saskatchewan Health Research Foundation (SHRF) College of Medicine Research Award (CoMRAD) CoMBRIDGE Fund Start-up Research Fund Based at Saskatoon City Hospital within the Cameco MS Neuroscience Research Centre, the Krishnan Lab trains students supported by NSERC USRA, Dean's project fellowships, OVDR Biomedical research fellowships, and Mitacs awards. The lab's strategic location adjacent to the Meewasin Valley provides collaborative opportunities for translational neuroscience research focused on nerve regeneration and cancer therapeutics.

• Nerve-tumor interface
• Nerve regeneration
• Cancer biology
• +۵ مورد دیگر

Professor Craig Sale holds the position of Professor of Human Physiology and Nutrition at Manchester Metropolitan University (MMU) and previously led research initiatives at Nottingham Trent University (NTU). He specializes in investigating exercise and nutrition interventions, particularly focusing on bone and muscle adaptations. His roles include Co-Lead of NTU’s Health & Wellbeing Strategic Research Theme, Director of the SHAPE Research Centre, and REF Unit of Assessment Coordinator for UoA C24. His research spans bone metabolism, muscle performance, genetics, sports nutrition, biomechanics, and environmental physiology, with a commitment to impactful real-world applications. His research has addressed topics such as beta-alanine supplementation for exercise performance, diet/exercise interventions for bone health in athletes, and the biological actions of carnosine. He has supervised 17 completed PhD students and currently guides 8 more. His awards include Fellowship in the American College of Sports Medicine (ACSM) and a Section Editor role at the European Journal of Sports Sciences. Recent work emphasizes bone biomarker responses to exercise, myocardial carnosine roles, and pregnancy’s legacy on athletic performance.

• Exercise Physiology
• Bone Metabolism
• Muscle Metabolism
• +۵ مورد دیگر

John Hanrahan is a Professor in the Department of Physiology at McGill University, leading the Cystic Fibrosis Transmembrane Regulator Function Laboratory. His research focuses on understanding epithelial chloride transport mechanisms, particularly the CFTR protein’s role in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). He employs electrophysiology, imaging, and molecular biology techniques to study CFTR structure-function relationships and develop therapeutic correctors for CFTR mutations. Education: BSc(Hon) from Dalhousie University, PhD from University of British Columbia, and postdoctoral training at Yale University. Research emphasizes: 1) CFTR clustering dynamics and lipid membrane interactions, 2) CFTR corrector drug development (e.g., MCG1516A, LAU-7b), 3) CFTR’s role in mucus production and host defense, and 4) pharmacological modulation of cyclic nucleotide pathways. Recent work explores combinations of CFTR modulators and lipid metabolism interventions to address CF pathophysiology. Key findings include demonstrating lipid-driven CFTR clustering defects in CF and identifying novel compounds that restore CFTR trafficking. His studies also reveal CFTR’s interplay with bitter taste receptors (T2R14) and PDE enzymes in immune responses.

• Cell Biology
• Molecular Biology
• Cystic Fibrosis Research
• +۳ مورد دیگر

Jixun Zhan is a Professor in the Department of Biological Engineering at Utah State University (USU), where he leads research in metabolic engineering, natural product biosynthesis, and biocatalysis. His work integrates systems biology, synthetic biology, and enzyme engineering to reprogram microbes for production of high-value pharmaceuticals and bioactive compounds. He holds a PhD in Natural Products Chemistry from East China University of Science and Technology (2003), an MS in Fermentation Engineering from Tianjin University (2000), and a BS in Fermentation Engineering from Nanchang University (1997). Research focuses on engineering microbial platforms for: 1) production of plant-derived natural products via synthetic biology approaches, 2) discovery of novel antimicrobial agents through combinatorial biosynthesis, and 3) development of biocatalytic systems for value-added metabolite modifications. Key innovations include engineered E. coli strains producing anticancer cyclooligomer depsipeptides and fungal systems for flavonoid glycosylation. Recipient of numerous awards including 6 consecutive Outstanding Researcher awards (USU Biological Engineering 2011-2017), NIH Academic Research Enhancement Award (2010), and American Heart Association Scientist Development Grant (2009). Holds 81+ peer-reviewed journal articles and 3 book chapters, with recent work published in Nature Communications , Proceedings of the National Academy of Sciences , and Metabolic Engineering . Teaching responsibilities include core courses like Metabolic Engineering I and Biological Engineering Design , with over 15 years of graduate mentorship. Current research group collaborates with industry on drug discovery and biocatalyst development, with active projects in peanut allergy therapy using natural product formulations.

• Metabolic Engineering
• Natural Product Biosynthesis
• Biocatalysis
• +۵ مورد دیگر

Dr. Kazem Kazerounian is a Professor of Mechanical Engineering at the University of Connecticut, affiliated with the School of Mechanical, Aerospace, and Manufacturing Engineering. He holds B.S., M.S., and Ph.D. degrees in Mechanical Engineering from the University of Illinois at Chicago (1980–1984). His expertise spans analytical and computational kinematics/dynamics applied to bio-nano machines, robotics, gear systems, and product design with health/ergonomics focus. He is a Fellow of ASME and recipient of the ASME Lifetime Achievement Award (2006) and George Wood Award (1997). Research interests include protein-based nano-scale devices, gear system dynamics, robotic manipulation, and creativity in engineering education. He consults for OSIM International (Singapore), Pratt & Whitney, and the Singapore Productivity & Standards Board. Editorial roles include ASME Applied Mechanics Review, Journal of Medical Devices, and Journal of Mechanisms and Machine Theory. Awards: ASME Lifetime Achievement Award (2006), George Wood Award (1997), ABB Outstanding Faculty Award (1997) Consulting: OSIM International, Pratt & Whitney, Singapore Productivity & Standards Board His work bridges mechanical engineering with bio-nano systems, emphasizing interdisciplinary applications in medicine and robotics. Over 150 publications span topics like nanorobotics, orthosis design, and computational protein folding models.

• Nano-Mechanical Systems
• Robotics
• Gear Systems Dynamics
• +۴ مورد دیگر

Jeremy Edwards serves as a Professor in the Department of Chemistry at the University of New Mexico, where he maintains an active research program at the intersection of pharmaceutical chemistry, genomics, and computational biology. His work spans multiple disciplines with a particular focus on developing innovative technologies for DNA sequencing and analysis. Professor Edwards' research interests center around Pharmaceutical Chemistry, Quantitative Biology, and Genomic Technologies. His work has significantly contributed to the fields of metabolic engineering, genome sequencing, and systems biology. He has pioneered approaches in nanopore sequencing technology and developed computational frameworks for analyzing complex biological systems. His research group has made notable contributions to understanding metabolic networks through flux balance analysis and in silico modeling, with applications ranging from bacterial metabolism to mammalian systems. Analysis of Professor Edwards' publication record reveals a strong trend toward developing cutting-edge genomic technologies and computational approaches for biological analysis. His recent work focuses on spatial transcriptomics, nanopore sequencing innovations, viral genome surveillance, and target illumination for drug discovery. The publications demonstrate a consistent trajectory from foundational metabolic modeling work toward increasingly sophisticated genomic technologies and applications in drug target identification and validation. Professor Edwards has established himself as a leader in computational genomics with an extensive publication record including highly cited papers such as "In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data" (1297 citations) and "The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities" (1295 citations). His work on metabolic modeling has been particularly influential in systems biology. As an active researcher, Professor Edwards has mentored numerous students and collaborators, though specific student names aren't documented in the available materials. His research has attracted significant funding supporting the development of genomic technologies and computational approaches. His laboratory appears to focus on the intersection of bioinformatics, molecular biology, and engineering, with particular emphasis on next-generation sequencing technologies and their applications. Professor Edwards leads a research group that integrates computational modeling with experimental approaches to tackle challenges in genomic analysis and metabolic engineering. His team has developed innovative tools like the Sentieon Genomics Tools, described as "a fast and accurate solution to variant calling from next-generation sequence data." The group's work spans from fundamental research on DNA sequencing technologies to applied projects in viral surveillance and drug target identification.

• Pharmaceutical Chemistry
• Quantitative Biology
• Genomics
• +۵ مورد دیگر

Jakob Körbelin is a Principal Investigator at the University Medical Center Hamburg-Eppendorf (UKE), affiliated with the Faculty of Medicine and the II. Medical Clinic and Polyclinic. His research focuses on vascular biology, gene therapy, and neurological disorders, particularly targeting the blood-brain barrier using adeno-associated viral (AAV) vectors. He leads studies on pulmonary hypertension, neurovascular interactions, and genetic diseases like Niemann-Pick type C2. His work bridges basic science and translational medicine, emphasizing AAV engineering and therapeutic applications. Key research interests include endothelial cell biology, neuroinflammation, and the pathophysiology of vascular diseases. Notably, he received the UCCH Hubertus Wald Young Investigator Award 2013 for his contributions. His lab explores mechanisms of vascular dysfunction, gene delivery optimization, and the impact of viral vectors in treating rare diseases. Collaborations span molecular neurobiology, immunology, and translational oncology. Publications highlight breakthroughs in AAV-mediated therapies, such as reversing neurodegeneration in NPC2 models and identifying novel targets for pulmonary hypertension. Ongoing projects address microvascular brain pathology in SARS-CoV-2 infection and the role of transcription factors in vascular diseases.

• Gene Therapy
• Vascular Biology
• Neurology
• +۳ مورد دیگر

Dr. Matthew James Slater is the Head of the Aquaculture Research Group at the Alfred Wegener Institute, focusing on sustainable marine bioeconomy. His work emphasizes integrated multitrophic aquaculture (IMTA), holothurian ecology, and economic development through aquaculture. He leads applied research with industry partners to develop sustainable feed solutions and improve aquaculture practices. Research interests include optimizing feed ingredients from by-products (e.g., black soldier fly larvae, shrimp processing remains) and exploring the ecological roles of sea cucumbers. He investigates the effects of environmental factors (soundscapes, light, temperature) on aquatic species and promotes circular economy principles in aquaculture. Key contributions span over 60 peer-reviewed publications, with recent work on microplastic contamination in fish and the economic value of small-scale fisheries. His research integrates interdisciplinary approaches to address global challenges in aquaculture sustainability and food security. Contact: matthew.james.slater@awi.de | +49(471)4831-2727 | Alfred Wegener Institute, Bussestraße 27, 27570 Bremerhaven

• Aquaculture
• Integrated Multitrophic Aquaculture (IMTA)
• Marine Biology
• +۳ مورد دیگر